The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients
暂无分享,去创建一个
[1] B. Astor,et al. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes , 2018, BMC Nephrology.
[2] Deepali Kumar,et al. Cytomegalovirus infection and graft rejection as risk factors for pneumocystis pneumonia in solid organ transplant recipients: A systematic review and meta‐analysis , 2018, Clinical transplantation.
[3] R. Redfield,et al. Impact of High‐Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients , 2018, Pharmacotherapy.
[4] S. Jordan,et al. Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients , 2017, Journal of immunology research.
[5] M. Olsen,et al. Delayed-Onset Cytomegalovirus Disease Coded During Hospital Readmission After Kidney Transplantation , 2014, Transplantation.
[6] R. Borrows,et al. Increased Graft Failure and Mortality Following Cytomegalovirus Disease in Kidney Transplant Recipients Undergoing Contemporary Immunosuppression and CMV Prophylaxis.: Abstract# D2450 , 2014 .
[7] T. Kim,et al. Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients , 2014, Transplant infectious disease : an official journal of the Transplantation Society.
[8] A. Caliendo,et al. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation , 2010, Transplantation.
[9] J. Fishman,et al. Infectious complications of antilymphocyte therapies in solid organ transplantation. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] F. Schmidt. Meta-Analysis , 2008 .
[11] J. Fishman. Infection in solid-organ transplant recipients. , 2007, The New England journal of medicine.
[12] S. Brouard,et al. Long-Term Cell Monitoring of Kidney Recipients After an Antilymphocyte Globulin Induction With and Without Steroids , 2007, Transplantation.
[13] W. Tsang,et al. Cytomegalovirus infection and graft rejection in renal transplantation: a single-center experience. , 2003, Transplantation proceedings.
[14] T. Larson,et al. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. , 2001, The Journal of infectious diseases.
[15] M. Mihatsch,et al. CYTOMEGALOVIRUS INFECTION AND GRAFT REJECTION IN RENAL TRANSPLANTATION , 2001, Transplantation.
[16] C. Pouteil‐Noble,et al. Cytomegalovirus prophylaxis with antiviral agents in solid organ transplantation: a meta-analysis. , 1998, Transplantation.
[17] D. Snydman,et al. Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients , 1995, Annals of Internal Medicine.
[18] R. Rubin,et al. Infection in the renal transplant recipient. , 1981, The American journal of medicine.
[19] J. Moorhead,et al. Infection in the Renal Transplant Patient , 1978, Journal of the Royal Society of Medicine.
[20] R. Redfield,et al. High-Dose Acyclovir for Cytomegalovirus Prophylaxis in Seropositive Abdominal Transplant Recipients , 2018, The Annals of pharmacotherapy.
[21] A. Schwarz,et al. Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] R. Rubin. Infection in the Organ Transplant Recipient , 1994 .